Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression

Clinical trial NCT07146503 · RECRUITING

Trial details

NCT number: NCT07146503
Sponsor: Riccardo Guglielmo
Status: RECRUITING
Study type: OBSERVATIONAL

Depression and Quality of Life Treatment Resistant Depression (TRD)Anhedonia Apathy Anxiety Cognition Temperament Psychiatric Comorbidities

Start date: 2022-11-01
Primary completion: 2026-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.